Skip to content
‹ Back to IndustriesSciences

3D-printed live bacteria creates world’s first “living tattoo”

MIT researchers have developed 3D-printed tattoos using genetically modified bacteria. This innovative technique allows tattoos to be 'living', responding to different stimuli. The breakthrough combines biology and technology, creating patterns that change with environmental changes.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · ·
Share
3D-printed live bacteria creates world’s first “living tattoo”

Key takeaways

01

MIT has created a technique for 3D-printed tattoos using genetically modified bacteria.

02

Living tattoos can change their appearance in response to environmental stimuli.

03

This innovation blends biology and tech, advancing tattoo design with responsive patterns.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Things are alive at MIT these days, even tattoos! Recently, it was a team over at the university that was experimenting with genetically modified bacteria cells that led them into creating a new technique of 3D printing regarding tattoo design. It was through this concept that something special occurred, a living tattoo that provided varied responses based on different provocations.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Drug makers often sign CDMO renewals before they know when generics arrive

Drug makers often sign CDMO renewals before they know when generics arrive

Drug makers often renew contract manufacturing deals before they can tell when generics will launch. Novartis's Entresto sales fell 43% in the fourth quarter of 2025 after US generic entry in the third quarter. The risk sits in minimum-batch commitments and two-year auto-renewals.

  • 01In the term-sheet framework described by Gerry Kennedy of Keystone Law, pricing, batch quantities, cancellation and capacity are agreed before any legal drafting starts.

Nov 5, 2026

Waters buys MOBILion to push into the $2 billion LC-MS proteomics market

Waters buys MOBILion to push into the $2 billion LC-MS proteomics market

Waters Corporation bought MOBILion Systems and its SLIM ion mobility technology as part of its LC-MS proteomics push, a market Waters sizes at $2 billion. Its existing business grew 9% to $871 million on routine drug and environmental testing. Proteomics is still a research bet.

  • 01Waters' acquisition of MOBILion targets the $2 billion LC-MS proteomics market.
  • 02Waters is pitching SLIM as a gas-phase separation step for proteomics workflows.
  • 03Waters' core laboratory business has seen a 9% growth to $871 million, fueled by testing demand.

Nov 4, 2026

What an ELN connects to is the real buying test

What an ELN connects to is the real buying test

As ELN adoption broadens, the real test is whether the notebook connects to other systems. Genedata argues an ELN embedded in a shared data model can reduce brittle handoffs in biologics workflows.

  • 01A survey of 150 scientists suggests reuse across disconnected systems has become a technical job, making import/export burden a practical benchmark of whether integration is working.

Nov 4, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512